Gene expression analysis of tumor scRNAseq data demonstrated a significant upregulation in pathways related to T cell activation and differentiation, cell adhesion, and cytokine production post-sotigalimab for both CD8+ and CD4+ T cells (Fig. 3D). The gene discussed is CD8A; the disease is neoplasm.